≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart CD2_INSITU_RECTUM_EXALLC for full statistics.

Carcinoma in situ of rectum

DOID EFO Endpoint Browser

CD2_INSITU_RECTUM

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • not C3_RECTUM
516613

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D01.2&
  • Hospital discharge: ICD-9 — 2304
  • Cause of death: ICD-10 — D01.2&
  • Cause of death: ICD-9 — 2304
  • Cancer registry: Topography ICD-O-3 — C20
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 2

3 out of 7 registries used, show all original rules.

262

4. Check minimum number of events

None

262

5. Include endpoints

None

262

6. Filter based on genotype QC (FinnGen only)

262

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
D01
Name in latin
Carcinoma in situ hepatis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 262 108 154
Unadjusted period prevalence (%) 0.06 0.04 0.07
Median age at first event (years) 70.09 69.02 70.83

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
233
Matched controls
2329
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
73.0
130.2
148
54
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
46.4
120.9
157
99
8263/2-C20.9
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS
+∞
105.4
93
*
C209, 8211, 2
ICD-O-3
NA
+∞
61.2
56
*
C209, 8148, 2
ICD-O-3
NA
+∞
53.2
49
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
36.3
49.8
64
24
WX402
NOMESCO Finland
General anaesthesia
7.7
38.9
110
243
UJF32
NOMESCO Finland
Coloscopy
6.5
38.1
141
446
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
82.4
37.4
41
6
WX302
NOMESCO Finland
Thoracal epidural anesthesy
15.0
35.8
62
55
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
31.5
34.8
46
18
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
12.5
31.0
58
60
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
10.8
28.2
57
68
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
21.7
27.3
40
22
JGA73
NOMESCO Finland
Transanal excision of lesion of rectum
72.7
23.4
26
*
JFF23
NOMESCO Finland
Transversostomy
50.6
22.9
27
6
UJG02
NOMESCO Finland
Proctoscopy
23.6
21.9
31
15
B01AB05
ATC
enoxaparin; parenteral
3.7
19.3
121
529
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
48.3
18.6
22
5
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
28.6
15.9
21
8
TPH07
NOMESCO Finland
Cathetrisation of artery
4.7
15.1
56
148
JGA75
NOMESCO Finland
Endoscopic microsurgical excision of lesion of rectum
+∞
14.7
14
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
25.7
14.0
19
8
JGA85
NOMESCO Finland
Endoscopic mucosal or submucosal resection in rectum
57.0
14.0
16
*
WX600
NOMESCO Finland
Single shot through catheter
17.6
13.7
21
13
8140/2-C20.9
ICD-O-3
Adenocarcinoma in situ, NOS, of rectum, NOS
+∞
13.7
13
*
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
148.3
13.6
14
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
5.9
13.3
38
74
C209, 8213, 2
ICD-O-3
NA
+∞
12.6
12
*
JGB04
NOMESCO Finland
Laparoscopic partial proctectomy with partial excision of mesorectum
+∞
12.6
12
*
D01.2
ICD-10 Finland
Carcinoma in situ: Rectum
+∞
12.6
12
*
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
137.1
12.6
13
*
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
137.1
12.6
13
*
K62.1
ICD-10 Finland
Rectal polyp
17.1
12.4
19
12
JG1CG
NOMESCO Finland
Extensive MRI of rectum
39.9
12.4
15
*
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
11.4
12.1
22
21
L01BC06
ATC
capecitabine; oral
7.7
11.7
27
39
R4110
NOMESCO Finland
Physiotherapy
2.8
11.4
92
437
JG1BG
NOMESCO Finland
MRI of rectum
26.6
11.3
15
6
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
11.2
76
320
B01AB10
ATC
tinzaparin; parenteral
4.7
10.0
34
81
JN4AD
NOMESCO Finland
Body CT examination
4.3
9.9
37
97
130
Kela drug reimbursment
Malignant tumour
3.9
9.3
39
114
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
6.2
9.2
24
42
Z71.8
ICD-10 Finland
Other specified counselling
2.8
9.1
69
309
TJF80
NOMESCO Finland
Ostomy education
25.2
9.0
12
5
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
93.3
8.5
9
*
TQW40
NOMESCO Finland
Remowal of suture of skin
4.4
8.3
30
76
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.5
8.0
20
33
WF001
NOMESCO Finland
Preoperative radiotherapy
19.1
7.7
11
6
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
82.6
7.5
8
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
4.2
7.1
26
68
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
5.7
6.9
19
36
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
5.5
6.1
17
33
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
13.0
6.1
10
8

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022145) Colonoscopy Study observation
185
275
20.49
139.87
2.3
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
157
279
12.55
98.40
6.1
4.4
ug/l
12.9
51.3
0.73
130
237
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
216
1032
7.23
39.89
5.5
4.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
98
259
5.45
36.75
1.8
3.0
umol/l
5.6
9.1
1.74
87
229
(3032080) INR in Blood by Coagulation assay
204
1004
5.66
34.05
12.0
9.8
inr
1.3
1.3
0.02
59
271
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
81
200
5.41
32.47
1.9
2.6
u/l
34.4
34.4
0.00
69
167
(3024561) Albumin [Mass/volume] in Serum or Plasma
203
1043
5.20
30.74
7.7
5.0
g/l
34.5
35.2
0.96
198
975
(3044640) Blood type and Crossmatch panel - Blood
164
721
4.41
30.72
3.6
2.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
128
542
3.66
23.77
3.7
2.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
204
1207
4.12
21.74
10.5
6.9
umol/l
11.1
11.7
0.59
199
1144
(3002256) Pathology report gross observation
79
271
3.74
19.69
1.3
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
162
866
3.28
19.46
2.7
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
118
542
3.14
18.12
1.5
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
139
715
3.01
17.24
3.8
3.4
e6/l
21.1
155.2
0.86
101
555
(3013826) Glucose [Moles/volume] in Serum or Plasma
209
1359
3.66
17.02
7.3
4.9
mmol/l
6.7
6.8
0.56
200
1276
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
48
135
4.13
15.62
10.2
9.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
89
374
3.09
15.58
3.2
3.1
e6/l
0.9
1.4
0.79
44
206
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
75
5.06
14.95
3.0
2.2
u/ml
0.3
0.3
0.00
15
39
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
116
579
2.80
14.64
2.3
2.1
mg/l
2.7
3.1
1.51
101
504
(36304419) Bacteria [Presence] in Urine
122
626
2.78
14.58
3.5
3.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
144
809
2.73
14.32
4.6
4.0
e6/l
42.7
120.7
1.29
103
590
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
82
346
2.99
14.07
3.1
2.4
%
21.5
21.9
0.07
74
299
(3030467) Casts [#/volume] in Urine by Automated count
124
653
2.71
13.93
3.7
3.2
e6/l
0.2
0.5
1.31
86
488
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
148
853
2.69
13.83
3.6
3.3
—
—
—
0
0
(4035726)
57
213
3.14
11.92
1.6
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
126
718
2.45
11.42
7.1
5.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
175
1159
2.54
11.34
9.7
7.0
mmol/l
1.2
1.2
2.03
148
980
(3023368) Bacteria identified in Blood by Culture
121
681
2.44
11.23
6.6
4.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
153
958
2.44
11.15
16.1
10.4
e9/l
0.0
0.0
0.43
121
789
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
84
402
2.60
10.99
2.9
2.9
e6/l
0.6
1.0
1.34
39
232
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
163
1071
2.38
10.35
8.1
6.0
mmol/l
1.2
1.2
2.00
152
960
(3026782) Osmolality of Urine
91
464
2.47
10.33
3.5
3.2
mosm/kgh2o
525.0
566.9
1.25
81
394
(3002030) Lymphocytes/100 leukocytes in Blood
159
1041
2.34
10.08
6.7
5.7
%
23.8
26.4
2.10
153
974
(3006504) Eosinophils/100 leukocytes in Blood
155
1018
2.28
9.56
6.8
5.5
%
2.7
2.9
0.49
150
951
(3019069) Monocytes/100 leukocytes in Blood
155
1025
2.25
9.31
6.9
5.8
%
9.0
8.8
0.28
150
966
(3002173) Hemoglobin [Mass/volume] in Arterial blood
59
257
2.67
9.18
9.6
7.9
g/l
115.9
120.3
0.98
54
250
(3013707) Erythrocyte sedimentation rate by Westergren method
214
1635
2.69
9.07
4.5
4.2
mm/h
16.0
13.4
1.26
208
1481
(3019198) Lymphocytes [#/volume] in Blood
161
1106
2.18
8.48
6.5
5.6
e9/l
1.7
1.8
0.21
140
979
(3031040) Bacteria [#/volume] in Urine by Automated count
195
1449
2.35
8.43
5.1
4.5
e6/l
5107.8
321.8
—
6
28
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
252
2141
5.64
8.34
28.2
16.5
mg/l
33.2
24.9
3.32
241
1737
(3019550) Sodium [Moles/volume] in Serum or Plasma
255
2258
5.84
8.32
34.5
19.4
mmol/l
139.5
139.6
0.28
255
2196
(3023103) Potassium [Moles/volume] in Serum or Plasma
255
2264
5.73
8.15
35.2
19.5
mmol/l
4.0
4.0
1.57
255
2202
(3013115) Eosinophils [#/volume] in Blood
161
1117
2.14
8.13
6.9
5.8
e9/l
0.2
0.2
1.13
139
988
(3020564) Creatinine [Moles/volume] in Serum or Plasma
255
2271
5.60
7.97
35.2
19.8
umol/l
89.4
82.0
1.38
255
2271
(3001604) Monocytes [#/volume] in Blood
157
1084
2.12
7.96
6.5
5.5
e9/l
0.6
0.6
0.14
132
939
(3006315) Basophils [#/volume] in Blood
157
1086
2.11
7.90
6.5
5.5
e9/l
0.0
0.0
1.47
132
946
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
255
2275
5.52
7.79
16.8
11.2
u/l
24.2
25.7
1.08
255
2185
(3003396) Base excess in Arterial blood by calculation
62
300
2.40
7.64
9.3
7.4
mmol/l
0.5
1.2
0.72
52
245
(3026008) Bacteria identified in Urine by Culture
111
682
2.09
7.60
3.3
3.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
114
710
2.07
7.50
4.5
4.2
ph
7.4
7.4
0.06
26
129
(3027945) Reticulocytes/100 erythrocytes in Blood
61
296
2.38
7.46
3.0
2.6
%
1.9
1.9
0.21
56
268
(3023520) Reticulocytes [#/volume] in Blood
50
222
2.55
7.40
4.4
2.7
e9/l
68.8
71.4
0.21
30
175
(3013650) Neutrophils [#/volume] in Blood by Automated count
175
1283
2.10
7.27
13.3
9.6
e9/l
4.2
4.2
0.01
145
1130
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
14
27
5.42
7.05
4.2
1.7
pg
35.3
32.7
1.96
14
27
(3000991) Gas panel - Venous blood
47
208
2.53
6.98
12.3
8.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
119
769
2.00
6.94
5.1
3.5
mmol/l
2.3
2.3
0.04
108
669
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
54
3.93
6.78
1.8
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
241
2047
3.21
6.71
31.3
15.2
ml/min/173m2
73.8
76.5
1.16
205
1685
(3044889) 12 lead EKG panel
201
1588
2.14
6.37
4.9
4.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
34
134
2.77
6.33
12.8
9.7
mmol/l
24.4
24.5
0.07
34
125
(3000850) Epithelial cells [#/volume] in Urine
84
498
2.01
6.10
3.0
2.7
e6/l
4.3
4.3
0.01
75
441
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
39
170
2.52
5.96
1.4
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
50
245
2.29
5.91
4.7
3.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
146
1057
1.86
5.69
4.0
4.0
estimate
0.0
0.0
0.00
38
201
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
111
738
1.87
5.66
2.8
2.6
u/l
60.9
55.6
0.69
104
683
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
135
955
1.85
5.65
2.3
2.0
pmol/l
92.2
93.4
0.13
90
505
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
68
383
2.05
5.64
1.7
2.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
126
873
1.85
5.63
2.4
2.3
nmol/l
79.9
76.9
0.52
114
766
(3037467) Urinalysis macro (dipstick) panel - Urine
190
1502
1.96
5.58
5.4
4.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
45
218
2.28
5.44
1.4
2.1
ug/g
217.7
155.7
0.25
37
183
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
30
4.51
5.36
3.2
2.1
e9/l
3.8
5.5
1.37
13
30
(3007461) Platelets [#/volume] in Blood
255
2344
4.29
5.24
42.7
24.0
e9/l
239.3
240.5
0.11
250
2279
(3024731) MCV [Entitic volume]
255
2346
4.25
5.24
42.7
24.0
fl
91.8
91.6
0.42
255
2306
(3035941) MCH [Entitic mass]
255
2346
4.25
5.24
42.5
23.9
pg
30.3
30.5
0.95
255
2306
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
13
31
4.36
5.15
4.2
3.0
%
51.7
60.0
0.70
13
31
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
33
143
2.50
5.10
1.3
1.8
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
255
2348
4.22
5.08
43.2
24.1
g/l
127.4
135.3
11.75
255
2305
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
115
794
1.80
5.05
4.2
3.4
ng/l
1942.9
1343.1
0.88
105
689
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
174
1362
1.83
4.96
4.0
3.4
u/l
60.7
53.7
0.42
161
1272
(40768797) Stomach Pathology biopsy report
56
307
2.05
4.95
1.4
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
144
1068
1.77
4.91
5.5
5.4
estimate
0.0
0.0
0.00
43
200
(3003458) Phosphate [Moles/volume] in Serum or Plasma
58
327
1.99
4.74
7.0
5.4
mmol/l
1.0
1.0
0.10
53
300
(3009261) Glucose [Presence] in Urine by Test strip
144
1080
1.74
4.62
4.0
4.0
estimate
0.0
0.0
0.00
39
186
(3042936) Bacteria identified in Isolate by Culture
61
353
1.95
4.62
2.6
2.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
247
2214
3.02
4.53
25.9
15.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
50
274
2.02
4.41
1.7
2.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
191
1568
1.80
4.32
4.4
3.7
pmol/l
15.4
15.0
1.19
173
1388
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
50
276
2.00
4.32
1.7
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
87
580
1.75
4.15
4.4
3.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
35
173
2.18
4.02
5.6
3.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
73
470
1.77
3.90
3.8
3.7
ng/l
276.3
266.7
0.02
63
397
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
78
513
1.74
3.87
1.8
1.8
pmol/l
460.0
448.4
0.11
66
422
(3026493) Urate [Moles/volume] in Serum or Plasma
88
602
1.70
3.77
3.3
2.9
umol/l
3488.3
7974.9
0.59
77
514
(3009542) Hematocrit [Volume Fraction] of Blood
215
1865
1.85
3.62
35.3
17.6
%
37.8
39.5
2.68
157
1256
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
71
468
1.71
3.45
4.9
3.1
mmol/l
2.5
2.5
0.29
66
413
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
222
1955
1.89
3.42
5.4
4.5
mu/l
2.0
2.6
0.50
204
1741
(3021960) Folate [Moles/volume] in Serum or Plasma
84
583
1.65
3.35
1.8
1.6
nmol/l
19.4
20.3
0.25
78
485
(4034850)
0
83
0.00
3.19
0.0
9.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
64
422
1.68
3.08
1.2
1.2
u/ml
2.5
1.4
0.36
19
123
(3023199) Leukocytes [#/volume] in Pleural fluid
10
29
3.55
3.08
1.6
1.2
e6/l
698.8
1917.5
—
5
22
(3034860) Kappa light chains.free [Mass/volume] in Serum
19
81
2.45
3.06
2.3
4.6
mg/l
66.3
144.1
0.48
13
66
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
19
81
2.45
3.06
2.3
4.6
mg/l
59.6
38.6
0.58
13
67
(40767503) Oxygen content in Capillary blood by calculation
14
51
2.84
3.03
3.3
2.6
%
17.1
15.3
—
9
23
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
123
2.14
2.93
2.1
2.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
53
2.73
2.84
1.5
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
28
146
2.03
2.83
1.3
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
23
4.01
2.80
1.7
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
31
169
1.95
2.77
1.7
2.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
139
1126
1.50
2.67
2.3
2.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
81
587
1.55
2.62
3.7
3.2
ug/l
0.7
0.8
0.28
57
397
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
234
2139
1.88
2.60
4.9
5.0
mmol/l
5.9
6.1
1.38
220
1946
(3028626) Oxygen [Partial pressure] in Capillary blood
14
56
2.58
2.57
2.9
2.1
kpa
8.1
8.0
0.17
14
50
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
16
4.46
2.49
3.1
2.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
12
45
2.75
2.48
5.4
3.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
14
58
2.49
2.41
1.6
5.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
29
163
1.88
2.39
4.7
4.8
%
0.1
0.2
—
8
48
(40758558) Short blood count panel - Blood
76
557
1.51
2.31
8.7
6.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
66
2.35
2.29
1.2
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
225
2051
1.69
2.29
6.8
6.4
mmol/mol
40.0
40.7
0.64
213
1902
(3000093) Morphology [Interpretation] in Blood Narrative
8
23
3.55
2.29
1.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
18
3.96
2.26
1.0
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
17
80
2.20
2.24
2.4
4.5
—
2.8
—
0
9
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
87
2.15
2.23
3.6
3.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
30
176
1.80
2.17
4.5
4.5
%
0.0
0.2
—
9
58
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
15
298
0.47
2.16
6.9
8.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
31
2.97
2.09
1.4
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
31
2.97
2.09
2.7
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
29
171
1.78
2.07
5.4
6.9
mmol/l
24.4
24.6
0.13
24
164
(40760892) CBC W Ordered Manual Differential panel - Blood
64
462
1.51
2.07
4.7
5.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
63
2.29
2.05
1.3
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
21
112
1.95
2.03
1.2
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
32
2.88
2.02
1.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
65
475
1.49
1.98
2.1
1.7
nmol/l
1079.9
1225.0
0.59
49
359
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
51
2.42
1.98
1.2
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
125
1035
1.40
1.93
5.5
5.3
ug/l
2.0
2.8
1.06
115
917
(3000494) Fungus identified in Specimen by Culture
42
281
1.59
1.90
1.5
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
108
1.92
1.87
1.6
1.7
g/l
3.9
3.8
0.19
13
78
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
108
1.92
1.87
1.6
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
108
1.92
1.87
1.5
1.7
g/l
7.1
7.5
0.71
15
83
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
234
2181
1.68
1.85
5.2
5.4
mmol/l
2.5
2.6
1.32
214
1983
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
102
821
1.40
1.84
4.4
4.7
%
20.5
21.1
0.17
54
416
(1761868) Lipid panel - Serum or Plasma
89
700
1.41
1.83
3.6
3.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
23
3.10
1.81
2.0
1.9
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
30
2.72
1.74
1.5
1.5
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
7
24
2.97
1.73
1.3
1.3
u/l
258.7
297.4
—
7
24
(3021901) Oxygen saturation in Capillary blood
11
48
2.35
1.73
3.2
2.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
29
181
1.68
1.72
4.7
4.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
193
1739
1.42
1.70
38.0
22.0
g/l
329.5
332.4
3.99
193
1734
(3002179) Metamyelocytes/100 leukocytes in Blood
27
166
1.70
1.69
4.1
4.4
%
0.3
0.4
—
6
43
(3037121) Protein [Mass/volume] in Urine
16
83
1.99
1.68
3.9
3.1
g/l
0.7
0.3
—
8
34
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
102
831
1.37
1.68
4.5
4.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
49
2.30
1.66
1.5
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
31
201
1.62
1.60
1.3
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
30
193
1.63
1.60
4.5
4.4
%
0.3
0.9
—
9
66
(3012441) Differential panel - Pleural fluid
7
27
2.64
1.52
1.7
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
65
2.05
1.51
1.7
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
20
117
1.77
1.50
6.0
3.5
mmol/l
23.2
23.9
0.37
20
105
(3021879) Hepatitis B virus core Ab [Presence] in Serum
21
125
1.74
1.49
1.2
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
9
39
2.35
1.44
1.1
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
38
266
1.50
1.43
2.4
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
33
224
1.54
1.42
6.5
3.8
mmol/l
0.6
1.7
0.59
27
177
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
40
2.29
1.41
3.9
3.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
19
112
1.75
1.39
3.9
3.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
74
589
1.36
1.38
4.9
4.2
estimate
0.0
0.0
0.00
41
191
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
31
209
1.55
1.38
1.3
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
52
390
1.42
1.38
1.4
1.4
g/l
2.8
2.7
0.06
29
228
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
17
2.98
1.36
2.4
1.9
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
17
2.98
1.36
1.0
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
20
311
0.61
1.29
4.0
4.9
%
31.3
31.1
0.03
13
206
(4281824)
5
18
2.81
1.29
1.6
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
44
2.08
1.28
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
44
2.08
1.28
1.2
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
93
1.77
1.24
1.1
1.0
—
—
—
0
0
(4306422)
6
26
2.34
1.19
1.7
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
35
0.00
1.16
0.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
225
2125
1.42
1.16
4.7
4.9
mmol/l
4.4
4.5
0.63
209
1944
(3020682) Albumin/Creatinine [Ratio] in Urine
91
764
1.29
1.15
4.2
3.9
mg/mmol
29.3
9.7
1.09
59
497
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
36
0.00
1.15
0.0
3.1
—
29.5
—
0
11
(3011397) Hemoglobin [Presence] in Urine by Test strip
62
494
1.33
1.14
2.7
3.8
—
—
—
0
0
(3012544) pH of Venous blood
33
236
1.46
1.14
6.6
3.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
30
2.37
1.13
1.4
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
51
2.00
1.12
1.3
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
11
192
0.55
1.11
1.9
3.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
8
41
1.98
1.09
3.1
2.1
mmol/l
1.5
1.6
—
8
41
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
33
2.15
1.06
1.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
46
1.99
1.04
1.2
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
22
2.30
1.04
1.6
2.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
34
2.09
1.03
1.6
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
34
2.09
1.03
1.0
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
61
493
1.31
1.02
4.5
1.8
mg/l
2.5
1.4
1.29
51
398
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
9
48
1.91
1.01
1.4
1.2
u/l
203.5
26.0
—
9
40
(3022806) Fractional oxyhemoglobin in Capillary blood
7
35
2.03
1.00
3.0
2.0
%
87.6
88.8
—
7
35
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
35
2.03
1.00
1.0
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
111
970
1.25
0.99
3.6
4.2
ng/l
35.8
40.7
0.22
87
735
(3023183) Ammonium ion [Moles/volume] in Plasma
10
54
1.89
0.98
7.8
3.6
umol/l
33.7
34.6
—
10
46
(3004809) Band form neutrophils/100 leukocytes in Blood
7
36
1.97
0.98
3.0
3.5
%
0.9
1.2
—
7
29
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
62
1.81
0.95
1.8
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
27
2.25
0.94
2.2
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
222
2110
1.34
0.93
4.6
4.8
mmol/l
1.4
1.4
0.07
205
1916
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
28
2.17
0.92
1.5
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
30
2.02
0.87
1.2
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
33
249
1.37
0.87
1.4
1.5
—
—
—
0
0
(3013512) EKG study
83
713
1.24
0.85
4.6
4.4
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
31
1.96
0.85
1.5
1.6
ug/l
14.7
19.2
—
6
31
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
73
1.67
0.83
1.4
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
81
1.64
0.83
2.3
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
32
1.90
0.82
1.0
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
215
2045
1.29
0.81
4.1
4.3
mmol/l
1.3
1.3
0.02
199
1849
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
66
1.70
0.80
1.5
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
96
0.51
0.80
1.6
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
33
1.84
0.79
2.2
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
26
0.00
0.79
0.0
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
26
0.00
0.79
0.0
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
26
0.00
0.79
0.0
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
15
219
0.67
0.77
1.5
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
39
309
1.31
0.76
1.3
1.3
u/ml
27.3
12.4
0.33
15
117
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
83
1.60
0.76
1.5
2.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
17
116
1.50
0.76
4.2
4.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
38
1.86
0.74
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
56
1.63
0.73
1.9
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
56
1.63
0.73
1.9
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
39
1.82
0.73
2.0
1.9
—
—
—
0
0
(3009343) pH of Capillary blood
21
153
1.41
0.69
3.8
3.4
ph
7.4
7.4
—
6
18
(3042631) Mycobacterium sp identified in Specimen
5
27
1.87
0.69
1.8
2.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
83
730
1.20
0.67
2.1
2.1
u/l
101.8
222.4
4.06
78
681
(3019225) pH of Specimen
17
233
0.71
0.64
3.2
3.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
69
599
1.21
0.63
1.6
1.7
mmol/l
1.3
1.3
0.13
59
499
(3015235) Bicarbonate [Moles/volume] in Capillary blood
11
71
1.57
0.63
5.4
2.3
mmol/l
24.8
24.6
0.06
11
60
(3009508) Creatinine [Moles/volume] in Urine
83
735
1.19
0.62
3.1
3.0
mmol/l
7.3
7.5
0.22
68
609
(21494434) Karyotype in Bone marrow
5
30
1.68
0.61
1.2
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
21
157
1.37
0.61
4.0
3.3
kpa
5.1
5.0
0.11
21
146
(3038026) Centromere Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
81
717
1.19
0.60
3.1
3.1
mg/l
913.0
327.0
0.37
50
476
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
22
0.00
0.59
0.0
3.0
—
40.1
—
0
8
(3007566) Smooth muscle Ab [Titer] in Serum
8
53
1.53
0.59
1.1
1.2
—
46.0
—
0
5
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.3
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
47
1.50
0.48
1.4
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
57
1.42
0.42
1.6
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
57
1.42
0.42
6.1
3.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
43.1
—
0
11
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
35
1.44
0.39
1.6
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
5
35
1.44
0.39
1.0
1.1
u/ml
364.4
238.8
—
5
15
(3023419) Bacteria identified in Sputum by Culture
5
36
1.40
0.38
5.0
2.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
36
1.40
0.38
1.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
72
1.40
0.37
5.5
5.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
37
1.36
0.37
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
5
37
1.36
0.37
1.0
1.4
—
238.7
—
0
12
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
21
255
0.81
0.37
1.0
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
25
208
1.22
0.37
1.4
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.36
1.5
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
38
334
1.16
0.32
1.4
1.3
iu/ml
16.8
39.9
2.21
14
107
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
16
129
1.26
0.31
1.1
1.4
—
38.9
—
0
9
(3003327) Ova and parasites identified in Stool by Light microscopy
7
54
1.30
0.30
1.3
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
57
1.23
0.29
1.4
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
18
152
1.20
0.24
1.4
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
7
93
0.75
0.23
1.4
2.5
u/l
40.3
38.2
—
7
83
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
116
1.22
0.22
1.1
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
11
135
0.81
0.22
1.4
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
41
1.22
0.22
1.2
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
23
201
1.16
0.22
2.6
2.1
nmol/l
420.8
377.6
0.74
23
183
(3028026) IgM [Mass/volume] in Serum or Plasma
16
135
1.20
0.22
3.2
1.8
g/l
2.1
1.3
0.51
16
122
(4010399)
20
173
1.17
0.21
1.1
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
22
192
1.16
0.21
6.0
2.9
kpa
5.1
4.3
0.78
22
181
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
11
0.00
0.21
0.0
1.5
—
55.2
—
0
6
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(44806420)
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
4.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
10
0.00
0.21
0.0
2.7
—
17.1
—
0
10
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
104
0.76
0.21
1.4
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
12
0.00
0.21
0.0
1.3
—
2.2
—
0
7
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
22.3
—
1330.8
—
0
12
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
18.0
—
895.1
—
0
12
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
13
0.00
0.21
0.0
1.5
—
139.9
—
0
13
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
13
0.00
0.21
0.0
1.1
—
7.9
—
0
13
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
9.0
—
0
6
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
99
1.22
0.20
1.4
1.2
iu/ml
90.2
162.7
—
7
34
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
17
146
1.18
0.20
2.1
2.5
—
5.9
—
0
5
(3000492) Spirometry study
22
196
1.13
0.17
1.7
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
71
1.13
0.16
1.4
3.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
72
1.11
0.16
1.5
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
17
150
1.14
0.15
2.4
2.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
112
1.17
0.14
3.9
3.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
11
126
0.87
0.11
5.8
2.8
%
1.1
1.2
0.22
11
126
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
134
1.13
0.11
1.7
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
47
1.07
0.09
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
56
1.07
0.08
2.2
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
113
0.88
0.08
1.2
1.3
—
—
—
0
0
(4094501)
6
58
1.04
0.08
1.2
1.1
—
—
—
0
0
(1002224) Polysomnography panel
6
74
0.81
0.07
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
17
184
0.92
0.07
4.6
2.8
ml/min/173m2
46.4
61.2
—
10
84
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
87
1.04
0.07
1.2
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
101
0.89
0.06
1.4
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
46
469
0.98
0.02
3.7
4.4
kg/l
1.0
1.0
—
6
63
(3020891) Body temperature
11
103
1.07
0.02
5.0
4.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
89
1.01
0.00
1.3
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.5
—
53.5
—
0
6
(42529406) Shigella sp [Presence] in Stool by Culture
6
63
0.95
0.00
1.0
1.3
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
9
0.00
0.00
0.0
1.1
—
3.6
—
0
9
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
1.1
—
0
5
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
62
0.97
0.00
1.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
43.0
—
0
5
(3037756) Immunofixation for Serum or Plasma
6
61
0.98
0.00
2.0
1.7
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
77
0.91
0.00
1.3
1.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
18.6
—
0
5
(3016244) Insulin [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
10.8
—
0
9
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
52
0.96
0.00
1.0
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
55
0.91
0.00
1.2
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
52
0.96
0.00
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
61
0.98
0.00
1.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_RECTUM – Carcinoma in situ of rectum

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).